Tauriga Sciences, Inc. Stock Other OTC
Equities
TAUG
US87669X2053
Pharmaceuticals
Financials (USD)
Sales 2020 | 0.23 | Sales 2021 | 0.29 | Capitalization | 29.3M |
---|---|---|---|---|---|
Net income 2020 | -3M | Net income 2021 | -3M | EV / Sales 2020 | 15,901,203 x |
Net Debt 2020 | 373K | Net cash position 2021 | 1.04M | EV / Sales 2021 | 99,058,952 x |
P/E ratio 2020 |
-0.87
x | P/E ratio 2021 |
-6.09
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 17-07-04 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 21-03-07 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Director/Board Member | 46 | 21-03-07 |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |